Members |
targetComponentId |
Disinfectant |
Antiseptic and/or disinfectant (substance) |
Disinfectant |
Antiseptic and/or disinfectant (substance) |
Disinfectant causing toxic effect |
Poisoning by antiseptic and/or disinfectant (disorder) |
Disinfectant dye |
Disinfectant dye (substance) |
Disinfectant soap |
Antiseptic and/or disinfectant (substance) |
Disinfectants and cleansers |
Anti-infective agent (substance) |
Disinfectants and cleansers adverse reaction |
Anti-infectives adverse reaction |
Disinhibition caused by ingestible alcohol |
Disinhibition caused by ethanol |
Dislocated finger NOS |
Dislocation of joint of finger (disorder) |
Dislocated finger NOS |
Dislocation of joint of finger (disorder) |
Dislocated spine NOS |
Dislocation of joint of spine |
Dislocated spine NOS |
Dislocation of joint of spine |
Dislocation reduction of lower limb NOS |
Reduction of dislocation of lower limb (procedure) |
Dislocation reduction of lower limb NOS |
Reduction of dislocation of lower limb (procedure) |
Dislocation reduction of upper limb NOS |
Dislocation reduction - upper limb |
Dislocation reduction of upper limb NOS |
Dislocation reduction - upper limb |
Disodium edetate allergy |
Allergy to edetate (finding) |
Disodium etidronate adverse reaction |
Adverse reaction to etidronic acid |
Disodium etidronate allergy |
Allergy to etidronic acid (finding) |
Disodium etidronate and calcium carbonate allergy |
Allergy to etidronic acid (finding) |
Disodium pamidronate adverse reaction |
Adverse reaction to pamidronic acid (disorder) |
Disodium pamidronate allergy |
Allergy to pamidronic acid (finding) |
Disodium tiludronate |
Product containing tiludronic acid (medicinal product) |
Disopyramide phosphate 100mg capsule |
Product containing precisely disopyramide (as disopyramide phosphate) 100 milligram/1 each conventional release oral capsule (clinical drug) |
Disopyramide phosphate 100mg m/r capsule |
Disopyramide only product in oral dose form |
Disopyramide phosphate 100mg m/r tablet |
Disopyramide only product in oral dose form |
Disopyramide phosphate 100mg prolonged-release oral capsule |
Disopyramide only product in oral dose form |
Disopyramide phosphate 100mg prolonged-release oral tablet |
Disopyramide only product in oral dose form |
Disopyramide phosphate 150mg |
Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each conventional release oral capsule (clinical drug) |
Disopyramide phosphate 150mg capsule |
Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each conventional release oral capsule (clinical drug) |
Disopyramide phosphate 150mg m/r capsule |
Disopyramide only product in oral dose form |
Disopyramide phosphate 150mg prolonged-release oral capsule |
Disopyramide only product in oral dose form |
Disorder by body site |
Disease |
Disorder involving the integument of fetus or newborn, NEC |
Fetal and/or neonatal disorder of integument |
Disorder of autonomic nervous system caused by substance |
Disorder of autonomic nervous system |
Disorder of balance |
Impairment of balance (finding) |
Disorder of bone, unspecified |
Disorder of bone (disorder) |
Disorder of bone, unspecified |
Disorder of bone (disorder) |
Disorder of heart caused by Salmonella enterica subspecies enterica serovar Typhi |
Infection of heart caused by Salmonella enterica enterica serovar Typhi |
Disorder of the immune mechanism NOS |
Disorder of immune function (disorder) |
Disorder of the immune mechanism NOS |
Disorder of immune function (disorder) |
Disorder of transport, NEC |
Metabolic disorder of transport |
Disorder of uterus NOS |
Disorder of uterus |
Disorder of uterus NOS |
Disorder of uterus |
Disorder of uterus NOS |
Disorder of uterus |
Disorder presenting primarily with chorea |
Involuntary movement characterised by brief, unpredictable, irregular, non-stereotyped movements that flow randomly from one body part to another. |
Disorders of cervix (& [NOS]) |
Disorder of uterine cervix |
Disorders of cervix (& [NOS]) |
Disorder of uterine cervix |
Disorders of cervix NOS |
Disorder of uterine cervix |
Disorders of cervix NOS |
Disorder of uterine cervix |
Disorders of the sacrum NOS |
Disorder of sacrum |
Disorders of the sacrum NOS |
Disorder of sacrum |
Dispensing of unlisted low vision aid |
Fitting and dispensing of spectacles |
Displaced tooth |
Displaced tooth |
Displacement - action |
Action |
Displacement, first degree |
Displacement |
Displacement, second degree |
Displacement |
Displacement, third degree |
Displacement |
Disproportion - major pelvic abnormality with antenatal problem |
Disproportion - major pelvic abnormality |
Disproportion NOS |
Disorder of pelvic size and disproportion |
Disproportion NOS |
Disorder of pelvic size and disproportion |
Disproportion NOS |
Disorder of pelvic size and disproportion |
Disproportion of other origin, NEC |
Disproportion between fetus and pelvis (disorder) |
Disrupted episiotomy wound |
Disruption of episiotomy wound in the puerperium (disorder) |
Disrupted laceration wound site |
Disrupted wound |
Dissecting aneurysm of coronary artery |
Dissection of coronary artery (disorder) |
Disseminated chorioretinitis and retinochoroiditis NOS |
Disseminated chorioretinitis |
Disseminated paracoccidioidomycosis |
Disseminated paracoccidioidomycosis (disorder) |
Dissociative convulsions |
An epileptic seizure originating within networks limited to one hemisphere. They may be discretely localised or more widely distributed. Focal seizures may originate in subcortical structures. |
Dissociative convulsions |
An epileptic seizure originating within networks limited to one hemisphere. They may be discretely localised or more widely distributed. Focal seizures may originate in subcortical structures. |
Dist fasciocutaneous flap NOS |
Distant fasciocutaneous flap |
Distal interphalangeal joint structure of great toe |
Interphalangeal joint structure of great toe |
Distal monosomy 20q syndrome |
A rare chromosomal anomaly syndrome resulting from the partial deletion of the long arm of chromosome 20 with a highly variable phenotype typically characterized by hypotonia, intellectual disability, cognitive and language deficits (including decreased or absent speech), pre and post-natal growth retardation, feeding difficulties, microcephaly, and malformed hands and feet. Neurodevelopmental disorders (including hyperactivity, social interactive problems and autism spectrum disorder), seizures and dysmorphic facial features (high forehead, hypertelorism, malformed ears, broad nasal bridge, bulbous nasal tip, thin upper lip, small chin) are frequently associated. |
Distal myopathy with early respiratory muscle involvement |
Hereditary myopathy with early respiratory failure |
Distant cutaneous pedicle skin flap NOS |
Reconstruction using distant pedicle skin flap |
Distant fasciocutaneous flap to head or neck NEC |
Distant fasciocutaneous flap |
Distant free flap reconstruction - action |
Distant flap reconstruction - action (qualifier value) |
Distant myocutaneous flap NOS |
Distant myocutaneous flap |
Distant myocutaneous flap to head or neck NEC |
Distant myocutaneous flap |
Distant pedicle flap reconstruction - action |
Distant flap reconstruction - action (qualifier value) |
Distant skin flap to head or neck NEC |
Reconstruction with distant flap (procedure) |
Distant subcutaneous pedicle flap, axial pattern NEC |
Reconstruction using distant subcutaneous pedicle axial pattern flap (procedure) |
Distant subcutaneous pedicle flap, fasciocutaneous NEC |
Distant fasciocutaneous flap |
Distant subcutaneous pedicle flap, myocutaneous NEC |
Distant myocutaneous flap |
Distant subcutaneous pedicle flap, random pattern NEC |
Reconstruction using distant subcutaneous pedicle random pattern flap (procedure) |
Disto-occlusion |
Disto-occlusion of teeth |
Disturbance in form of thinking |
Disorder of form of thought |
Dithranol cream allergy |
Allergy to dithranol (finding) |
Dithranol ointment allergy |
Allergy to dithranol (finding) |
Dithranol paste allergy |
Allergy to dithranol (finding) |
Divalproex sodium 125mg tablet delayed release |
Product containing precisely valproic acid (as valproate semisodium) 125 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Divalproex sodium 250mg tablet delayed release |
Product containing precisely valproic acid (as valproate semisodium) 250 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Divalproex sodium 500mg m/r tablet |
Valproic acid only product in oral dose form |
Divalproex sodium 500mg prolonged-release oral tablet |
Valproic acid only product in oral dose form |
Diverticulitis of large intestine with complication |
Diverticulitis of large intestine |
Diverticulitis of large intestine without complication |
Diverticulitis of large intestine |
Diverticulitis of small intestine with complication |
Diverticulitis of small intestine |
Diverticulitis of small intestine without complication |
Diverticulitis of small intestine |
Diverticulosis NOS |
Multiple diverticula of intestine (finding) |
Diverticulosis NOS |
Multiple diverticula of intestine (finding) |
Diverticulosis of the large intestine NOS |
Diverticulosis of large intestine (finding) |